Patterson Companies Fiscal 2022 Fourth Quarter and Year End Conference Call Scheduled for Wednesday, June 29, 2022
Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2022 fourth quarter and year end conference call on Wednesday, June 29, 2022 at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens.
To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com.
The fiscal 2022 fourth-quarter and year end earnings conference call replay will be available beginning at 10 a.m. CT (11 a.m. ET) on June 29 through 10 p.m. CT (11 p.m. ET) on Wednesday, July 6, 2022. Interested persons may dial (800) 770-2030 and enter Conference ID 71954 when prompted.
About Patterson Companies Inc.
Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain is equaled only by our dedicated, knowledgeable people who deliver unrivalled expertise and unmatched customer service and support.
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024
First Quarter 2024
Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...
Galantas Gold Corporation (the ?Company') is pleased to announce its audited annual financial results for the year ended December 31, 2023. A copy of the Financial Statements and Management Discussion and Analysis will be sent to shareholders in due...
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.
The earnings release can be found at...
ICEYE, a global leader in satellite-powered disaster management solutions, has announced a new data collaboration with Juniper Re, LLC ("Juniper Re"), the dynamic reinsurance broking arm and indirect subsidiary of BRP Group, Inc. .
Juniper Re will...
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...